Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
11/2005
11/10/2005US20050250758 Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use
11/10/2005CA2563222A1 Novel imidazoles
11/10/2005CA2562400A1 Novel phenantridine analogues and their uses as inhibitors of hyperproliferation of t cells and/or keratinocytes
11/10/2005CA2562176A1 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
11/10/2005CA2555862A1 Polyamine analogs that activate antizyme frameshifting
11/09/2005EP1593677A2 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes
11/09/2005EP1593673A1 Acrylamide derivative, process for producing the same, and use
11/09/2005EP1593671A1 DPP-IV inhibitors
11/09/2005EP1592772A2 5ht7 antagonists and inverse agonists
11/09/2005EP1592696A1 Salts comprising cyanoborate anions
11/09/2005EP1592670A1 Mercaptoimidazoles as ccr2 receptor antagonists
11/09/2005EP1592669A2 Novel substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds
11/09/2005EP1476433B1 Novel tricycloimidazoline derivatives, method for production and use thereof as medicaments
11/09/2005EP1216223B1 Novel dicarboxylic acid derivatives with pharmaceutical properties
11/09/2005EP1095016B1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
11/09/2005CN1694873A Vanilloid receptor ligands and their use in treatments
11/09/2005CN1694864A N-bridged selective androgen receptor modulators and methods of use thereof
11/08/2005US6963010 Hydrophobic polyamine analogs and methods for their use
11/08/2005US6962937 Imidazolidine derivatives, their preparation and their use
11/08/2005CA2277164C Method of controlling polymer molecular weight and structure
11/08/2005CA2155104C Heterocyclic-substituted alkyl amide acat inhibitors
11/08/2005CA2123691C Antiviral compositions and method for their use
11/03/2005WO2004099165A3 Heterocyclic compounds and hydro isomers thereof
11/03/2005US20050245615 Treating proliferative cutaneous disease using a polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; e.g. lupus; use with other biosynthesis enzyme inhibitors
11/03/2005US20050245592 2-Iminopyrrolidine derivatives
11/03/2005US20050245586 2,5-Dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12
11/03/2005US20050245579 desferrithiocin analogs used as siderophores, for treatment of malaria in humans
11/03/2005US20050245542 Pyridazine, pyrimidine and pyrazine ethyne compounds
11/03/2005US20050245526 Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
11/03/2005US20050245512 Method and composition for rejuvinating cells, tissues organs, hair and nails
11/02/2005EP1590340A1 Inhibitors of histone deacetylase
11/02/2005EP1590338A2 Modulators of melanocortin receptor
11/02/2005EP1590331A1 Method of preparing an acylimidazolium-type reagent
11/02/2005EP1425007B1 Use of c2-substituted indane-1-ol systems for producing medicaments for the prophylaxis or treatment of obesity
11/02/2005EP1334084A4 Phosgene-free process for preparing carbamates
11/02/2005EP1278719B1 Naphthamide neurokinin antagonists for use as medicaments
11/02/2005EP1246807B1 Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
11/02/2005EP1159261B1 Antizyme modulators and their use
11/02/2005CN1692109A Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
11/02/2005CN1692108A Pesticidal heterocycles
11/02/2005CN1692103A 1-substituted 4-nitroimidazole compound and process for producing the same
11/01/2005US6960688 Use of compounds for the elevation of pyruvate dehydrogenase activity
11/01/2005US6960665 Process for arylating or vinylating or alkynating a nucleophilic compound
11/01/2005US6960605 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
11/01/2005US6960601 Imidazole derivatives; appetite suppressants
11/01/2005US6960600 a triazole or amidazole compound containing oxy, hydroxy or aromatic rings; active on candidoses, cryptococcoses caused by Candida albicans; prevention of mycosic diseases in individuals with immunodeficiency.
11/01/2005US6960586 Having a steroid C17,20-lyase inhibitory activity; useful as prophylactic or therapeutic agent for prostate and breast cancers
11/01/2005US6960567 Forming an intermediate compound N-((2S)- thiobenzoyl-4 (1,5,5-trimethylhydantoinyl)butanoyl)-L-leucyl-L- tert-leucine N-methylamide by an improved process that substantially reduces the presence of contaminants in the
10/2005
10/27/2005WO2005101020A1 Method for analyzing n-terminal protein adducts
10/27/2005WO2005100334A1 Dipeptidyl peptidase-iv inhibitors
10/27/2005WO2005100322A1 Sulphur-linked imidazole compounds for the treament of hiv
10/27/2005WO2005100318A1 Alkanoic acids and their esters as antidiabetic agents
10/27/2005WO2005100303A1 Indene derivatives and process for the preparation thereof
10/27/2005US20050240025 Method for producing imidazolium salts
10/27/2005US20050240023 Cathepsin cysteine protease inhibitors
10/27/2005US20050239898 Compounds for use in the treatment of aids and other viral diseases and HIV-related infections and compositions containing such compounds, methods of treating such diseases and infections and methods of making such compounds and compositions
10/27/2005US20050239860 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
10/27/2005US20050239857 Novel imidazoles
10/27/2005US20050239856 Method for prophylaxis and treatment of diabetic complications with 4{alpha-hydroxy-2-methyl-5-(1-imidazolyl)benzyl}-3,5-dimethylbenzoic acid and derivatives
10/27/2005US20050239836 Substituted hydroxyethylamine aspartyl protease inhibitors
10/27/2005US20050239790 Substituted hydroxyethylamine aspartyl protease inhibitors
10/27/2005US20050239054 Drug screening compounds having esterified phosphonate or carboxyl groups with novel enzyme GS-7340 Ester Hydrolase and identifying the compound as a suitable prodrug by the formation of a phosphonic acid or carboxylic acid; candidate compounds
10/27/2005CA2563026A1 Method for analyzing n-terminal protein adducts
10/27/2005CA2562846A1 Sulphur-linked imidazole compounds for the treament of hiv
10/26/2005EP1589007A2 5-membered heterocycle derivatives, production thereof and their use as medicaments
10/26/2005EP1587813A1 Phosphonium and imidazolium salts and methods of their preparation
10/26/2005EP1587473A2 Thiosemicarbazones as anti-virals and immunopotentiators
10/26/2005EP1341766B1 Imidazolone derivatives for the treatment of viral diseases
10/26/2005EP1307431B1 Efficient ligand-mediated ullmann coupling of anilines and azoles
10/26/2005EP1098870B1 Nitrate salt of Cetirizine
10/26/2005CN1688550A 2, 5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase MMP12
10/26/2005CN1688194A 2, 4, 5-trisubstituted imidazoles and their use as anti-microbial agents
10/26/2005CN1224598C Naphthalene derivatives
10/25/2005US6958402 3-(imidazolyl)-2-alkoxypropanoic acids
10/25/2005US6958356 Guanidine mimics factor Xa inhibitors
10/25/2005US6958353 Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts
10/25/2005US6958352 Compounds for inhibiting insulin secretion and methods related thereto
10/25/2005US6958240 Inhibition of major groove DNA binding proteins by modified polyamides
10/25/2005CA2147056C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
10/20/2005WO2005097765A1 Anaplastic lymphoma kinase modulators and methods of use
10/20/2005WO2005097755A2 Imidazol derivatives as tyrosine kinase inhibitors
10/20/2005WO2005061450A3 Hiv protease inhibiting sulfonamides
10/20/2005WO2005058845A3 Novel glucagon antagonists/inverse agonists
10/20/2005WO2005055715A3 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives
10/20/2005WO2005030794B1 Hemiasterlin derivatives and uses thereof
10/20/2005US20050234239 Method of forming a carbon-carbon or carbon-heteroatom linkage
10/20/2005US20050234125 Alpha-sulfonylamino-acetonitriles
10/20/2005US20050234118 Novel aryllimidazole derivatives, preparation and therapeutic used thereof
10/20/2005US20050234112 treatment of COPD (chronic obstructive pulmonary disease), inflammation; Betamimetics; long-lasting effect; potent; beta 2-adrenoreceptor; 4-[2-(1,1-dimethyl-3-[1,2,4]triazol-4-yl-propylamino)-1-hydroxy-ethyl]-2-hydroxymethyl-phenol
10/20/2005US20050234109 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine
10/20/2005US20050234106 1-aryl-1-heteroarylaminoalkylene-substituted, e.g., 1-[fluorophenylcyclohexylmethyl]isoquinolin-1-ylamine; antiarrhythmia agents; cardiovascular disorders
10/20/2005US20050234065 Dipeptidyl peptidase-IV inhibitors
10/20/2005US20050234061 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/20/2005US20050234041 Substituted 1-benzazepines and derivatives thereof
10/20/2005CA2561585A1 Imidazol derivatives
10/20/2005CA2559866A1 Anaplastic lymphoma kinase modulators and methods of use
10/19/2005EP1586558A2 Bis-sulfonamide hydroxyethylamino retroviral protease inhinitors
10/19/2005EP1585735A1 Hydroxamid acid derivatives as histone deacetylase (hdac) inhibitors
10/19/2005EP1585733A1 Heterocyclic ppar modulators
10/19/2005EP1585511A2 Asthma and allergic inflammation modulators
1 ... 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 ... 345